Nov. 8, 2024 — Lunit has announced new research findings demonstrating the potential of its artificial intelligence (AI) to predict immunotherapy treatment outcomes in rare tumors.

Nov. 4, 2024 – Shared Medical Services, Inc. (SMS) and Nebraska Medicine recently announced the deployment of the Philips Mobile MR 5300 BlueSeal magnet. The MR 5300 with BlueSeal technology is designed to provide helium-free MR imaging capabilities in a mobile format, increasing access to care with advanced medical diagnostics for communities in both rural and urban areas. 

Nov. 7, 2024 — Bayer announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD Centargo CT injection system, a multi-patient injector that drives workflow efficiency with design features that integrate with Bayer’s portfolio of products, especially in high-volume CT suites.

Bayer’s MEDRAD Centargo CT Injection System delivers value for radiology departments as the U.S. faces a shortage of radiology technologists coupled with a rising demand for medical imaging.

Nov. 1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures.

Oct 31, 2024 —Sirona Medical recently added added nine new radiology practices to its Unify platform. Among them are Kansas Imaging Consultants, Radiologic Associates of Fredericksburg, Diagnostic Medical Group of Southern California, Cascaid Health, Newport Diagnostic Center, and Jacobson Memorial Hospital.

Nov. 4, 2024  — Volpara Health has announced a new contract with the U.S. Defense Health Agency (DHA) valued at $7.3 million over five years. The contract will see Volpara's Patient Hub, an advanced mammography reporting, cancer risk assessment and patient tracking system, deployed across DHA's military health system. The goal is to modernize breast cancer screening and patient management for military personnel and their families.

Point-of-care ultrasound (POCUS) is increasingly prominent within undergraduate medical education – but what does this mean for educators, students and administrators?

Blue Earth Therapeutics Ltd, recently announced further positive developments for its novel investigational radioligand therapies. Enrollment of patients in the Phase 1 trial of Lutetium (177Lu) rhPSMA-10.1 Injection was completed in July.

Oct. 29, 2024 — NewVue and Enlitic recently announced a bi-directional strategic partnership that will leverage the proprietary AI algorithms of both companies to automate data standardization in radiology, solving a long-standing challenge faced by healthcare organization, eliminating the need for manual data normalization and transforming key areas such as PACS viewer hanging protocols, dictation system template selection, worklist case assignment and AI study analysis orchestration.

Oct. 23 , 2024 — Lunit  recently announced the findings from two large-scale studies evaluating its AI-powered mammography solution, Lunit INSIGHT MMG. The studies conducted by researchers at the Cancer Registry of Norway and Odense University Hospital in Denmark demonstrate the technology's potential to significantly improve breast cancer screening programs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now